Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_assertion description "[We selected ER-positive tumors, and clinical end points for the HOXB13-to-IL17BR ratio were disease-free survival (DFS) in patients with primary breast cancer (N = 619) and progression-free survival (PFS) in patients with recurrent breast cancer treated with first-line tamoxifen monotherapy (N = 193).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_assertion evidence source_evidence_literature NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_assertion SIO_000772 17308270 NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_assertion wasDerivedFrom befree-20140225 NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_assertion wasGeneratedBy ECO_0000203 NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP565620.RAd8GDAjgk_zw8uJVXj4pUAy0bGrBgRNk7I7wgzBMhNGw130_provenance.